Q2 2021 Passage Bio Inc Earnings Call Transcript
Good morning, and welcome to the Passage Bio Second Quarter 2021 Financial and Operating Results Conference Call. (Operator Instructions) Please be advised, this call is being recorded at the company's request.
At this time, I would like to turn it over to Stuart Henderson, Vice President of Investor Relations and Strategic Finance. Stuart, please begin.
[Thank you, operator. This morning, we issued a press release that] outlines the topics we plan to discuss today. This release is available on the Passage Bio website at investors.passagebio.com under the Press Releases and Statements section.
On today's call, Bruce Goldsmith, President and Chief Executive Officer, will review our second quarter 2021 financial results and discuss recent business highlights; Eliseo Salinas, our Chief R&D Officer, will review our key clinical updates; and Jill Quigley, our Chief Operating Officer, will also be available for the Q&A portion of the call.
Before we begin,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |